Lynne S. Taylor
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
Publications
605
Citations
27,674
Est. group size
~20
Recurring co-author estimate
Active years
51
Publishing since 1976
Lynne S. Taylor's research focuses on improving how poorly water-soluble drugs are formulated so they can be absorbed effectively when taken orally, particularly through the use of amorphous (non-crystalline) drug formulations mixed with polymers, known as amorphous solid dispersions. Her work examines how these formulations dissolve, release the drug, and pass through biological membranes under conditions meant to mimic the human gut. This research is relevant to students interested in pharmaceutical formulation science, drug delivery, and physical pharmacy.
Publication output has generally declined over the last decade from a 2020 peak (150 in that year, likely including an atypical surge) to a steadier average of about 19 per year in the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The expanding role of formulations to enable oral delivery of poorly water-soluble drugs
Nature Reviews Drug Discovery · 2026
- Role of Dissolution Medium pH in the Release Behavior of Basic Drug–Copovidone Amorphous Solid Dispersions
Molecular Pharmaceutics · 2026
- Announcing the Winners of the 2026 <i>Molecular Pharmaceutics</i> Early Career Best Paper Award
Molecular Pharmaceutics · 2026
- From Unwanted Annoyances to Oral Delivery Saviors: The Rollercoaster Journey of Amorphous Drugs
Molecular Pharmaceutics · 2025
- Impact of Permeation Enhancers on the Release of Insulin from Tablets in Biorelevant Media
Molecular Pharmaceutics · 2025
- Modification of Peptide and Permeation Enhancer In Vitro Release Rates by Dispersion with a Gel-Forming Polymer
Pharmaceutical Research · 2025
- Design and synthesis of cellulose ω-carboxythioalkyl alkanoate derivatives for amorphous solid dispersion of hydrophobic compounds
Carbohydrate Polymers · 2025
- Announcing the Winners of the 2025 <i>Molecular Pharmaceutics</i> Early Career Best Paper Award
Molecular Pharmaceutics · 2025
- Correction to “Selecting Counterions to Improve Ionized Hydrophilic Drug Encapsulation in Polymeric Nanoparticles”
Molecular Pharmaceutics · 2025
- 2024 AAPS 360 Annual Meeting: Highlights in the Area of In Vitro Release and Dissolution
Dissolution Technologies · 2025
- Coadministration of a crystalline drug compromises supersaturation and membrane transport of an amorphous drug
International Journal of Pharmaceutics · 2025
- Interplay of Drug–Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions
Molecular Pharmaceutics · 2024
- Impact of drug incorporation into micelle on reduced griseofulvin and meloxicam permeation across a hollow fiber membrane
Journal of Pharmaceutical Sciences · 2024
- Exploring biorelevant conditions and release profiles of ritonavir from HPMCAS-based amorphous solid dispersions
Journal of Pharmaceutical Sciences · 2024
- Chemistry and ionization of HPMCAS influences the dissolution and solution-mediated crystallization of posaconazole amorphous solid dispersions
Journal of Pharmaceutical Sciences · 2024
- Molecular Pharmaceutics×87
- Journal of Pharmaceutical Sciences×28
- Crystal Growth & Design×22
- Pharmaceutical Research×16
- International Journal of Pharmaceutics×16
- Niraj S. Trasi
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Rodolfo Pinal
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Chailu Que
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Haichen Nie
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
- Eric J. Munson
Pharmacology, Toxicology and Pharmaceutics · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile